Biden is also calling on all employers, regardless of size, to offer paid leave for their workers to get vaccinated — as well as urging companies to provide information about the shots and incentives to get them, like product giveaways or other rewards.
The announcements come as the administration is reaching a new turning point in its campaign to vaccinate over 300 million Americans: Supply is beginning to exceed demand, and appointments are going unfilled in both rural areas and big cities.
The problem goes beyond vaccine hesitancy and extends to Americans who have neither easy access to the shot nor the motivation to get vaccinated. State and federal officials say the focus is now on meeting people where they are.
“We are now approaching groups of people who are — just by the fact that they’re younger, they are less at risk, and therefore, the urgency might be a little bit lower,” an administration official told reporters on Wednesday. “It doesn’t mean that they’re hesitant to get the vaccine. It just means it needs to be more convenient for them.”
Before he took office, Biden pledged in December to administer 100 million vaccinations in his first 100 days, along with an objective of opening most schools nationwide.
Later that month, the Food and Drug Administration authorized emergency use of two vaccines from drugmakers Pfizer and Moderna, and public health experts predicted Biden’s vaccination target would be achievable given the government’s supply of shots.
But Biden expressed frustration with his coronavirus response team in January as transition officials became increasingly concerned about the 100-day timeline, citing internal divisions and the shortfalls of the Trump administration’s vaccine accelerator, Operation Warp Speed.
After Biden rolled out his own plan for a large-scale vaccination program, the immunization effort received another boost from the FDA’s authorization of drugmaker Johnson & Johnson’s single-shot vaccine, opening up a third option for U.S. use in February.
By March, Biden had easily surpassed his goal of 100 million vaccinations in 100 days, and he later announced a new mission to double the target in the same time period.
In recent weeks, the administration has had to contend with unexpected challenges in its vaccination campaign — chiefly, federal health agencies’ recommendation to pause the Johnson & Johnson vaccine as they investigate rare incidents of blood clots in recipients.
Administration officials are also grappling with the stubborn issue of vaccine hesitancy, particularly among Republicans and younger, white Americans who live in rural communities.